The modulation of the septohippocampal cholinergic pathway by glutamatergic or GABAergic inputs was studied by monitoring the outflow of ACh collected via a transversal microdialysis probe implanted into the hippocampus and other brain areas of freely moving rats. In one set of experiments a transversal microdialysis membrane was inserted in the dorsal hippocampus, drugs were administered intracerebroventricularly through a cannula implanted in the lateral ventricle, and ACh outflow in the dialysate was measured by an HPLC method with an electrochemical detector. The dialysis membrane was usually perfused with Ringer's solution containing 7 PM physostigmine sulfate. Intracerebroventricular injections of the NMDA antagonists 3-((W)-2-carboxypiperazin-4-yl)-propyl-1 -phosphonic acid (CPP; l-50 nmol), , and D(-)-P-amino-7-phosphonoheptanoic acid (100 nmol) brought about an increase in hippocampal ACh outflow while the non-NMDA antagonist 6,7-dinitroquinoxaline-2,3-dione (0.25-20 nmol) was without effect. The increase in ACh outflow following CPP administration was dose dependent and reached a maximum of about 500%. It was abolished by TTX (0.5 PM) delivered locally to the hippocampus via the dialysis membrane and prevented by intracerebroventricular injection of the GABA agonist muscimol (5 nmol). In a second set of experiments, one microdialysis membrane was inserted in the dorsal hippocampus to detect ACh outflow and another in the septum to administer drugs locally and at the same time detect septal GABA outflow. The septal dialysis membrane was perfused with Ringer's solution without physostigmine, and GABA levels in the dialysate were measured by an HPLC method with a fluorescence detector. CPP (100 PM) perfused through the septum resulted in a decrease in septal GABA outflow and a concomitant increase in hippocampal ACh outflow. Muscimol (100 PM) administration into the septum abolished the effect of CPP on hippocampal ACh outflow but did not affect septal GABA outflow. These results demonstrate that in the septum NMDA receptors tonically activate GABAergic neurons which in turn inhibit the cholinergic septohippocampal neurons. [Key words: hippocampus, septum, NMDA receptors, ACh outflow, GABA outflow, microdialysis]
The septohippocampal pathway, which originates from the medial septum and the nucleus of the diagonal band and projects diffusely to the Ammon's horn and dentate gyrus of the hippocampus, provides the main cholinergic input to the hippocampus (Nicoll, 1985) . The majority of the septohippocampal fibers are rich in AChE and ChAT Cue110 and Sofroniew, 1984) . Electrical stimulation of the medial septum is followed by an increase in ACh outflow from the hippocampus (Szerb, 1967) and enhances via muscarinic receptors hippocampal spikes evoked by commissural stimulation (Krnjevic and Ropert, 1982) .
The physiological and pharmacological properties of the medial septal neurons have been extensively studied (McLennan and Miller, 1974a,b; Lamour et al., 1984; Segal, 1986) . Electrophysiological data demonstrate that the medial septal cholinergic neurons are regulated by intrinsic interneurons through a GABAergic mechanism (McLennan and Miller, 1974a,b; Lamour et al., 1984; Segal, 1986; Dutar et al., 1989) .
Biochemical and pharmacological evidence indicates that there is also a glutamatergic hippocamposeptal pathway arising from the pyramidal neurons of the Ammon's horn and projecting to the lateral septum (Zaczek et al., 1979; Jijels and Urban, 1984; Stevens and Cotman, 1986) where it impinges on GABAergic interneurons (Malthe-Sorennsen et al., 1980) . These in turn project to the medial septum and are responsible for the major inhibitory input to the medial septal cholinergic neurons (McLennan and Miller, 1974a,b; Dutar et al., 1985) . On the other hand, pyramidal and nonpyramidal neurons from the hippocampus send more sparse but still important projections directly to the neurons of the medial septum (Gaykema et al., 199 1) . Therefore, the medial septal area can be considered a relay station of efferents to and afferents from the hippocampus. Vinogradova et al. (1980) and Dutar et al. (1987) suggested the existence of a tonic inhibitory input from the hippocampus to septal neurons.
The aim of our work was to investigate the modulation of the septohippocampal cholinergic neurons by glutamatergic inputs. For this purpose we studied the outflow of endogenous ACh from the hippocampus as an index of functional activity of cholinergic neurons (Pepeu, 1973) . ACh outflow from hippocampus was studied by means ofthe transversal microdialysis technique (Imperato and Di Chiara, 1984) in freely moving rats. We also implanted a second microdialysis probe in the septum. By means of this "dual membrane technique"
we perfused the drugs directly into the septum and at the same time we studied the effects of drugs on ACh outflow from the terminals of the septohippocampal neurons. Therefore, by this procedure it has been possible to study the effect of local application of drugs on two sequential steps in the same neuronal circuitry.
A preliminary report of this study has been presented (Giovannini et al., 1992) .
Materials and Methods
Animal housing and surgery. Male adult Charles River Wistar rats weighting 250-300 gm were used. They were housed in groups of three with free access to food and water and kept on a 12 hr light/ 12 hr dark cycle. The rats were anaesthetized with chloral hydrate (400 mg/kg, i.p.) and placed in a stereotaxic frame (Stellar, from Stoelting Co., Wood Dale, IL). Microdialysis tubes were inserted transversely into the septum, dorsal hippocampi, and both striata following the procedure described by Wu et al. (1988) . The microdialysis tubing (AN 69 membrane, Dasco, Italy) was covered with Super-Epoxy glue along the whole of its length except for a region corresponding to the brain areas to be studied (2 mm for the septum, 6 mm for the dorsal hippocampus, and two sections of 3.5 mm separated by a glued central zone 2.5 mm long for the striata). The coordinates used for the implantation of the microdialysis tubing were as follows (Paxinos and Watson, 1982) : for the septum, AP +0.9 mm and H 5 mm from bregma; for the dorsal hippocampi, AP -3.3 mm and H 3.3 mm from bregma; for the striata, AP 0.0 mm and H 5 mm from bregma. When necessary, a polyethylene cannula (length, 4 mm) was inserted in the lateral ventricle to allow the intracerebroventricular injection of the drugs. The coordinates used were AP -1.5 mm, L -1.5 mm from bregma. All coordinates were referred to bregma, with bregma and lambda on a horizontal plane.
Microdialysis procedure. One day after surgery each rat was placed in a Plexiglas cage. In one set of experiments a microdialysis probe was placed in the hippocampus or in the striatum and a polyethylene cannula in the lateral ventricle, when necessary. The microdialysis probe was perfused with Ringer's solution (NaCl, 147 mM; CaCl,, 1.2 mM; KCl, 4.0 mM; containing 7 PM physostigmine sulfate) at a constant flow rate of 2 @min using a microperfusion pump (Carnegie Medicine, model CMA/lOO, Stockholm, Sweden). The content of ACh and choline (Ch) in the dialysate was analyzed by HPLC as described below. Drugs were administered either locallv dissolved in Ringer's solution or by intracerebroventricular injection dissolved in 5 Fi of saline (flow rate, 5 & 15 set).
In the "dual membrane" set of experiments the rats were implanted with the dialysis membrane both in the septum and hippocampus (see the schematic diagram in Fig. 1 ). The microdialysis probe implanted in the septum was perfused with Ringer solution without physostigmine. Drugs were administered in the septum dissolved in Ringer's solution. The dialysates from the septum and hippocampus were collected for the analysis of GABA and ACh, respectively, as described below.
After 1 hr settling period the dialysate was collected at 20 min intervals and directly assayed for ACh and Ch or GABA. After collecting the first three or four samples to measure the basal outflow, drugs were injected intracerebroventricularly or delivered locally to the septum or hippocampus through the microdialysis membrane.
Histological control. At the end of the experiment the rats were anesthetized with urethane (1.2 gm/kg, i.p.) and killed by decapitation. In order to verify the exact positioning of the intracerebroventricular cannula, 5 ~1 of China ink was injected via the cannula before decapitation. The brain was rapidly removed and placed in a vial containing 10 ml of 9% phosphate-buffered formaldehyde solution. Two or three days later the brain was frozen with liquid CO, and coronal slices were cut using a freezing microtome. The 50-Frn-thick slices were observed under light microscopy (Leitz, Dialva 20 EB) to verify the positioning of the dialysis membrane. Data obtained from rats in which the dialysis membrane was positioned outside the structure under investigation and/or the intracerebroventricular cannulas outside the lateral ventricle were discarded. The conditions of the septal neurons around the probe were checked at the end of the experiment by staining coronal sections of paraformaldehyde-fixed brains with Richardson's solution (modified Nissl staining).
"In vitro" recovery experiment. In order to evaluate the recovery of ACh, Ch, and GABA through the microdialysis tubing "in vitro," recovery experiments were performed as described in Giovannini et al. (199 la) . The recovery of ACh and Ch from the dialysis membrane was 56 ? 0.6% and 60 k 0.7%. and 58 + 2.9% and 64 & 3.2% for the membrane used for the hippocampus and striatum, respectively. The recovery ofGABA was 38 + 8.0%. ACh, Ch, and GABA values reported here were not corrected for recovery. All the recovery experiments were performed at room temperature.
Assay of ACh and Ch in the dialysate. ACh and Ch were directly assayed in the dialysate using an HPLC method with an electrochemical detector as described by Damsma et al. (1987a) and Giovannini et al. (199 la, b) . Briefly, ACh and Ch were separated on a cation exchange column prepared by loading a reverse phase column (Chromspher 5 C18. Chromoack) with sodium laurvl sulfate (0.5 ma/ml) as described by Damsmakt al: (198713) . The mobile phase consisted of 0.2 M phosphate buffer (pH 8.0) containing 5 mM KCl, 1 mM tetramethylammonium (TMA), and 0.3 mM EDTA. The flow rate was 0.7 ml/min. ACh was hydrolyzed by AChE to acetate and Ch in a postcolumn enzyme reactor; Ch was oxidized by Ch oxidase to produce betaine and hydrogen peroxide. Hydrogen peroxide was electrochemically detected by a platinum electrode at +250 mV. For the quantitative analysis of ACh and Ch we constructed a calibration curve by spiking the Ringer's solution with standard ACh and Ch in the concentration range we expected to find in the dialysates. Three or four concentrations for each calibration curve were then injected at the beginning and the end of the analysis, and the heights of the recorded peaks were then plotted against the concentrations. A regression line was calculated and quantitation of unknown samples was carried out by the method of inverse prediction. Under these experimental conditions the sensitivity limit (s:n ratio, 3: 1) was 500 fmol for ACh and 250 fmol for Ch.
Assay of GABA in the dialysate. GABA analysis was carried out by an HPLC method after derivatization of the amino acid. The eouipment (Perkin-Elmer) consisted of a gradient pump series 3B and-650-10s fluorometric detector fitted with a 5 ~1 flow cell. The excitation wavelength was 340 nm and the emission wavelength was 455 nm. A Shimadzu C-R4A Chromatopac integrator was connected to the detector. A nucleosil Cl 8 column (200 nm x 4 mm i.d.; particle size 5 pm) was used. The mobile phase consisted of methanol-potassium acetate (0.1 M) plugged to pH 5.5 by glacial acetic acid and was run at 1.5 ml/min in two linear steps from 25% to 90% methanol (13 min) followed by an isocratic hold for a further 3 min. GABA was derivatized with o-phthalaldehyde (OPA) as described by Lenda and Svenneby (1980) except that the OPA concentration was 0.3 mg/ml and 50 mM HCI was used to dissolve the sample in preparation for the chromatographic run. The increased OPA concentration was necessary to ensure complete derivatization of the other amino acids. Homoserine was added as internal standard. One volume (10 ~1) of dialysate was mixed with two volumes of the derivatization reagent solution in glass capillaries. The contents were mixed and injected after 60 sec. Standard curves showed a linear relationship between the amount of fluorescence and the quantity of GABA applied to the column over the range 0.1-100 pmol. Under these experimental conditions the sensitivity limit (signal-to-noise ratio > 3) was 32 fmol.
Chemicals. All reagents were of analytical grade. Physostigmine sulfate, OPA, homoserine, tetrodotoxin (TTX), AChE (E.C. 3.1.1.7., grade VI-S), and Ch oxidase (E.C. 1.1.3.17) were purchased from Sigma Chemical Co. Statistical analysis. ACh and GABA outflow rates were expressed as percentage variation over basal output which (for each group of experiments) was the mean (+SEM) ofall predrug determinations. Significant differences were statistically evaluated on the percentage values using the ANOVA for repeated measures followed by Newman-Keuls multiple comparison test. Differences were considered significant at p < 0.05.
Results
Basal ACh outflow from the hippocampus of freely moving rats was 2.93 +-0.17 pmol/20 min (mean ? SEM; n rats = 42) and remained stable throughout the experiment (4 hr or more). Saline intracerebroventricular injections were followed by a small (maximum of 30-40%) increase in the outflow of ACh from the hippocampus, lasting only one collection period, associated with the handling of the animal and probably due to stress. When the membrane was positioned outside the hippocampus, ACh levels in the dialysate were very low, near the sensitivity limit of the detection method, and no drug effect was observed. These latter data were thus discarded.
The initial efflux of Ch from the hippocampus was 5 1.9 + 2.6 pmol/20 min (mean + SEM; n rats = 44) and decreased rapidly during the first 60 min of collection to a new steady state level, at about 50% of the initial value, 120 min after the beginning of the collection period. None of the drugs administered modified the efflux of Ch from the hippocampus.
Basal outflow of GABA from the septum of freely moving rats was 31.0 -t 5.28 pmol/20 min (n rats = 13) and remained stable throughout the experiment.
Administration of NMDA receptor antagonists
The intraventricular administration of the competitive NMDA antagonist CPP to rats implanted with an intracerebroventricular cannula in the right lateral ventricle and a microdialysis membrane in the hippocampus was followed by an increase in ACh outflow from the hippocampus. Figure 2A shows the time course of the increase for each dose tested (l-50 nmol), expressed as percentage change from the mean of the three collection periods before CPP administration (basal outflow). The time course of ACh outflow in control animals injected intracerebroventricularly with 5 ~1 saline is also shown. The effect of CPP began between 40 and 80 min after administration, was dose dependent in the range of l-50 nmol (as shown in Fig. 2B ) and appeared to be large and long lasting.
CPP administration elicited a complex behavior characterized by circling, and head and body weaving, superimposed on neck and limbs hypotonia and ataxia. Although a quantitative analysis of the behavioral effects elicited by the drug was not performed, their intensity appeared to be dose dependent and their time course was similar to that of the increase in ACh outflow. At the dose of 50 nmol the symptomatology was so intense that we considered unethical to repeat these experiments.
No change in ACh outflow from the striatum was observed after intracerebroventricular administration of 5 nmol of CPP (Fig. 2C) .
Local application of CPP to the hippocampus via the dialysis probe (100 hi CPP, dissolved in Ringer's solution, starting after three basal samples and lasting 100 min) had no effect on hippocampal ACh outflow (variations ranging between -9 and + 10%; n = 8).
The outflow of ACh from the hippocampus was completely abolished by local application of the Na+ channel blocker TTX (0.5 FM, dissolved in Ringer's solution) via the dialysis tubing (Fig. 3) . Following local administration of TTX (0.5 WM) via the dialysis tubing, CPP administration (5 nmol, i.c.v.) did not enhance the outflow of ACh that gradually fell to undetectable values (Fig. 3) . The effect of TTX shows that the increase in hippocampal ACh outflow brought about by CPP was dependent on propagated neuronal activity. The rats treated with both TTX and CPP displayed the same behavioral symptomatology as those treated with CPP alone, a finding indicating that either the behavioral effects did not depend on the increased ACh outflow, or that TTX did not diffuse so far as to block the effects of CPP on other parts of the hippocampus or on other nuclei. Figure 4 shows the effect of two other NMDA and one non-NMDA antagonists on the outflow of ACh from the hippocampus. Figure 4A shows that the competitive NMDA antagonist (D-APT, 100 nmol, i.c.v.) increased ACh outflow from the hippocampus 40 min after administration. The increase (80%) peaked 60 min after administration, lasted for about 1 hr and then gradually returned to basal values. Figure 4B shows the effect of two doses of the noncompetitive NMDA antagonist MK801 (5 and 20 nmol, i.c.v.) on ACh outflow from the hippocampus. While the dose of 5 nmol was ineffective, 20 nmol MK801 caused an increase in ACh outflow with a maximum (about 100%) 60 min after administration. The effect lasted for about 1 hr and then returned to basal values. Figure 4C shows the effect of three doses (0.25, 5, and 20 nmol, i.c.v.) of the non-NMDA receptor antagonist DNQX on the outflow of ACh from the hippocampus. None of the doses tested significantly enhanced the outflow of ACh.
Intracerebroventricular
administration of muscimol and CPP In order to demonstrate whether the effects of intracerebroventricular administration of CPP on ACh outflow from the hippocampus were due to an indirect action mediated via GABAergic neurons, the effect of a GABA agonist on hippocampal ACh outflow was studied. Figure 5A shows the effect of intracerebroventricular administration of two doses of muscimol(1 and 5 nmol) on the outflow of ACh from the hippocampus that appeared to be biphasic: an immediate and short-lasting increase (80% at the dose of 5 nmol), followed by a long-lasting decrease (50% below the basal outflow at the dose of 5 nmol). The administration of muscimol directly to the hippocampus via the microdialysis tubing (100 FM dissolved in Ringer's solution) after collecting four basal samples caused an increase (233%) in the outflow of ACh that peaked 60 min after the beginning of the perfusion and then gradually decreased (Fig. 5B) .
Muscimol (5 nmol, i.c.v.) administered 20 min after CPP (5 nmol, i.c.v.) completely prevented the effect of CPP on the outflow of ACh from hippocampus (Fig. 6) . As shown in Figures  5A and 6 , the time course of the effect elicited by administration of muscimol and CPP was similar to that observed with muscimol alone. All the points starting from time 120 min were significantly different from the basal samples.
"Dual membrane" experiments In order to administer the drug locally to the septum and to evaluate GABA outflow from the septum and ACh outflow from the hippocampus of the same animal, one microdialysis tubing was placed in the hippocampus and another one in the septum (see Fig. 1 ). The damage caused by the probe to the septal neurons was evaluated on Richardson's solution-stained septal sections. Neuron profiles and number appeared normal and no sign of inflammation was observed around the microdialysis membrane track.
Application of CPP (100 FM, dissolved in Ringer's solution without physostigmine) to the septum elicited both an increase 
I- in ACh outflow from the hippocampus (Fig. 7A ) and a decrease in GARA outflow from the septum of the same animal (Fig.   7B ). The effect of CPP on hippocampal ACh and septal GABA outflow was antagonized by the simultaneous administration to the septum of NMDA (200 PM, perfused through the dialysis membrane)
as shown in Figure 7 , A and B. When muscimol and CPP were administered together (100 PM, dissolved in Ringer solution without physostigmine), the effect of CPP and muscimol on the outflow of GABA did not differ from that observed with CPP alone (Fig. 7B ), but the effect of CPP on the outflow of ACh from the hippocampus was no longer evident ( Fig. 74 . When the microdialysis tubing was not positioned exactly in the septum, but in a nearby structure, neither GABA outflow from the septum nor ACh outflow from the hippocampus was modified by CPP (data not shown), indicating that this effect was not due to the interaction of the drug with NMDA receptors localized in adjacent structures, but rather to a direct action on receptors located in the septum.
Discussion
The aim of this research was to examine whether the septohippocampal cholinergic pathway is regulated "in vivo" by a glutamatergic input.
Our main findings were that (1) intracerebroventricular administration of the NMDA antagonists CPP, D-APT, or MK80 1 increased ACh outflow from the hippocampus; (2) local administration of CPP to the hippocampus had no effect on hippocampal ACh outflow; (3) local administration to the septum of the NMDA antagonist CPP was followed by a decrease in the outflow of GABA from the septum and by an increase in ACh outflow from the hippocampus; and (4) administration of muscimol completely prevented the effect of CPP on hippocampal ACh outflow, but had no effect on septal GABA outflow.
Taken together, these findings suggest that the increase in hippocampal ACh outflow elicited by NMDA receptor antagonists was mediated by NMDA receptors located on GABAergic neurons of the septum. It is important to emphasize that when the dialysis tubing was positioned in an area just outside the septum, no effect on GABA or ACh outflow was detected. This finding confirms that CPP locally administered to the septum elicits its effect on GABA and ACh outflow by interacting with NMDA receptors present in the septum and not by diffusing to more distant structures. However, the relatively large diameter of the dialysis tubing that was in contact with the lateral and medial septal areas did not allow identification of the exact region of the septum where such interaction occurred. No effect was obtained perfusing CPP directly in the hippocampus. This excludes local presynaptic effect on cholinergic nerve terminals Muscimol (100 PM) and/or CPP (100 PM) were dissolved in Ringer's solution without physostigmine and administered through the membrane after collection of four samples as shown by the horizontal bar. This system allowed the administration of drugs locally to the septum and the contemporaneous evaluation of their effects on GABA outflow from the septum and of ACh outflow from the hippocampus. ACh and GABA outflows are expressed as percentage changes over the mean of the first four samples, as controls (mean + SEM of at least five independent experiments and confirms previous results that NMDA has no effect on ACh outflow from hippocampal slices (Lehmann and Scatton, 1982; Ulus et al., 1992) . CPP or muscimol was administered by intracerebroventricular injection or locally to the septum. The estimated volume of ventricular space in the brain of adult rat is 200 ~1. Therefore, after intracerebroventricular injection of 5 nmol of CPP or muscimol, the concentration of the drug in the cerebrospinal fluid was presumed to be 10 PM, that is, IO-fold lower than that administered to the septum via the dialysis
